SPINK1 Genetic Variants in Pancreatitis.
Genetic variants disrupting the expression or function of the Serine Protease Inhibitor, Kazal Type 1 (SPINK1) gene—encoding the pancreatic secretory trypsin inhibitor (PSTI, also called SPINK1)—elevate the risk of pancreatitis and pancreatic cancer. This review elucidates SPINK1’s role as a key inhibitor of active trypsin, detailing its protective mechanism alongside other regulatory factors. We emphasize human SPINK1 variants, spotlighting the high-risk haplotype tagged by p.N34S (Table 1) and other risk, predisposing or pathogenic variants (Table 2). Additionally, we explore the conditions and co-factors—genetic and environmental—that trigger acute pancreatitis (AP) and progression to chronic pancreatitis (CP), providing a comprehensive framework for understanding SPINK1’s clinical significance
Authors
- Vinciane Rebours (ORCID: https://orcid.org/0000-0002-0000-4525)
- David C. Whitcomb (ORCID: https://orcid.org/0000-0002-4462-1410)
- Maham Waqar
Institutions
- King Edward Medical University (PK)
- University of Pittsburgh (US)
- Université Paris Cité (FR)
- Hôpital Beaujon (FR)
- Assistance Publique – Hôpitaux de Paris (FR)
Publication Details
- Journal
- SMART-MD journal of precision medicine.
- Published
- 2025-04-01
- DOI
- https://doi.org/10.69734/tbx0n188
- Primary Topic
- Pancreatitis Pathology and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00